Antifibrotic in interstitial lung diseases: When, where, and how long?

被引：3
|
作者：
Rai, Deependra K. [1 ]
Tripathi, Suryakant [2 ]
机构：
[1] AIIMS, Dept Pulm Med, Patna, Bihar, India
[2] KJMU, Dept Pulm Med, Lucknow, Uttar Pradesh, India
来源：
LUNG INDIA | 2022年 / 39卷 / 06期
关键词：
IDIOPATHIC PULMONARY-FIBROSIS; FORCED VITAL CAPACITY; DOUBLE-BLIND; PIRFENIDONE; NINTEDANIB; EFFICACY; SAFETY; UPDATE;
D O I：
10.4103/lungindia.lungindia_283_22
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：491 / 494
页数：4
相关论文
共 50 条
  • [1] Interstitial lung diseases: the role of HRCT in in the era of antifibrotic therapy
    Cruz Santana, Alfredo Nicodemos
    Nunes Soares, Flavia de Souza
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2020, 46 (05)
  • [2] Use of an Organoid Model to Evaluate Drug Antifibrotic Responses in Interstitial Lung Diseases
    Dsouza, K. G.
    Surolia, R.
    Kulkarni, T.
    Li, F.
    Singh, P.
    Zeng, H.
    Stephens, C. T.
    Wang, Z.
    Antony, V. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [3] Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
    Kevin G. Dsouza
    Ranu Surolia
    Tejaswini Kulkarni
    Fu Jun Li
    Pooja Singh
    Huaxiu Zeng
    Crystal Stephens
    Abhishek Kumar
    Zheng Wang
    Veena B. Antony
    Respiratory Research, 24
  • [4] Palliative Care in Interstitial Lung Disease: With the "Who," We Need the What, When, Where, and How
    Love, Gillian
    Pogue, Megan
    Kramer, Daniel
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E571 - E571
  • [5] Use of a pulmosphere model to evaluate drug antifibrotic responses in interstitial lung diseases
    Dsouza, Kevin G.
    Surolia, Ranu
    Kulkarni, Tejaswini
    Li, Fu Jun
    Singh, Pooja
    Zeng, Huaxiu
    Stephens, Crystal
    Kumar, Abhishek
    Wang, Zheng
    Antony, Veena B.
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [6] Antifibrotic treatment in progressive non-IPF fibrotic interstitial lung diseases
    Belen Llanos-Gonzalez, Ana
    Bordas Martinez, Jaume
    Bermudo Peloche, Guadalupe
    Suarez-Cuartin, Guillermo
    Vicens Zygmunt, Vanesa
    Planas-Cerezales, Lurdes
    Palma Lopez, Jose Manuel
    Perez Martin, Laura
    Jodar Masanes, Ramon
    Padulles Zamora, Nuria
    Garcia Gil, Sara
    Dorca Sargatal, Jordi
    Medina Gonzalvez, Agustin
    Acosta Fernandez, Orlando
    Molina Molina, Maria
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [7] Antifibrotic therapy - new approvals for non-IPF interstitial lung diseases
    Markart, Philipp
    Drakopanagiotakis, Fotios
    Wygrecka, Malgorzata
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (03) : 181 - 184
  • [8] Interstitial Lung Disease (ILD) - when and how to treat it?
    Krueger, K.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (08): : 780 - 781
  • [9] Use of antifibrotic Drugs in interstitial Lung Disease
    Kreutz, Claus-Peter
    Gesierich, Wolfgang
    Behr, Juergen
    Kneidinger, Nikolaus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (21) : 1383 - 1389
  • [10] Interstitial Lung Diseases How safe and effective is surgical Lung Biopsy?
    Lorenz, Judith
    ZENTRALBLATT FUR CHIRURGIE, 2016, 141 (01): : 10 - 11
12345